论文部分内容阅读
治疗哮喘的一种新方法正在不断地建立。英国研究者提供的极为有力证据表明,免疫系统中的T辅助细胞错误地过度激活,可以产生一系列称为细胞移动素(Cytokines)的“信使”蛋白质,启动连锁性的变化,导致气道收缩,哮喘发生,从而开辟了一条研制新一代治疗哮喘药物的途径。于33例严重慢性哮喘者用防止器官移植反应药物行对比实验研究,26例完成实验者症状明显改善。以前有人曾对轻度及过敏性哮喘的气道细胞研究,也发现一种称为T_(H2)细胞是这些抗原触发哮喘性疾病的主
A new method of treating asthma is constantly being established. There is strong evidence from British researchers that the mis-over-activation of T helper cells in the immune system can produce a series of “messenger” proteins called Cytokines that initiate cascading changes that lead to airway constriction , Asthma, which opened up a way to develop a new generation of asthma drugs. In 33 cases of severe chronic asthma were used to prevent organ transplant responders compared to the experimental study, 26 patients completed the trial symptoms were significantly improved. Someone had previously studied airway cells in mild and allergic asthma and also found that a cell called T H2 is the host of these antigens that trigger asthmatic diseases